Status:
COMPLETED
The Effectiveness of Email Alerting on Reducing Employees' Unauthorized Access to Protected Health Information
Lead Sponsor:
Protenus, Inc.
Conditions:
Unauthorized Data Access
Eligibility:
All Genders
Phase:
NA
Brief Summary
To assess the effectiveness of email warnings on reducing repeated unauthorized access to Protected Health Information (PHI), a randomized trial was conducted in a large academic medical center to und...
Detailed Description
From January 1, 2018, to July 31, 2018, a large academic medical center's PHI access monitoring system flagged all unauthorized accesses to patient electronic medical records from 444 employees (all p...
Eligibility Criteria
Inclusion
- violators of patients' privacy rights
Exclusion
- \-
Key Trial Info
Start Date :
January 1 2018
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
September 30 2021
Estimated Enrollment :
444 Patients enrolled
Trial Details
Trial ID
NCT05251844
Start Date
January 1 2018
End Date
September 30 2021
Last Update
February 23 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Protenus, Inc.
Baltimore, Maryland, United States, 21231